ICC Labs Inc (CVE:ICC) Director Michael Young sold 45,300 shares of ICC Labs stock in a transaction dated Monday, February 12th. The shares were sold at an average price of C$1.50, for a total value of C$67,950.00.
Michael Young also recently made the following trade(s):
- On Monday, February 5th, Michael Young bought 45,300 shares of ICC Labs stock. The stock was purchased at an average cost of C$1.46 per share, with a total value of C$66,138.00.
ICC Labs Inc (ICC) traded down C$0.01 during midday trading on Monday, reaching C$1.50. The company’s stock had a trading volume of 733,251 shares, compared to its average volume of 2,190,000. The firm has a market cap of $206.40 and a P/E ratio of -75.00. ICC Labs Inc has a 52 week low of C$0.96 and a 52 week high of C$2.00.
About ICC Labs
ICC Labs Inc produces and sells cannabis in Uruguay. It offers recreational cannabis, cannabinoid extracts, and by-products for medicinal use, as well as industrial hemp. The company was formerly known as ICC International Cannabis Corporation and changed its name to ICC Labs Inc in December 2017. ICC Labs Inc is headquartered in Montevideo, Uruguay.
Receive News & Ratings for ICC Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICC Labs and related companies with MarketBeat.com's FREE daily email newsletter.